Hyundai Pharm Overview
- Year Founded
-
1965
- Status
-
Public
- Employees
-
406
- Stock Symbol
-
004310
- Investments
-
2
- Share Price
-
$4.86
- (As of Thursday Closing)
Hyundai Pharm General Information
Description
Hyundai Pharmaceutical Co Ltd is a South Korea based company engage in the manufacturing and distribution of pharmaceutical products, health foods, and medical equipment.
Contact Information
Website
www.hyundaipharm.co.krCorporate Office
- Bonegeunsa Street 135
- Hyundai Pharm Building, Gangnam-gu
- Seoul, 06121
- South Korea
Corporate Office
- Bonegeunsa Street 135
- Hyundai Pharm Building, Gangnam-gu
- Seoul, 06121
- South Korea
Hyundai Pharm Stock Performance
As of 12-Nov-2026, Hyundai Pharm’s stock price is $4.86. Its current market cap is $150M with 30.9M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.86 | $4.98 | $2.37 - $11.06 | $150M | 30.9M | 4.08M | $0.08 |
Hyundai Pharm Financials Summary
As of 31-Aug-2026, Hyundai Pharm has a trailing 12-month revenue of $142M.
|
In Thousands, USD |
TTM 31-Aug-2026 | FY 2025 30-Nov-2025 | FY 2024 30-Nov-2024 | FY 2023 30-Nov-2023 |
|---|---|---|---|---|
| EV | 165,450 | 96,914 | 92,153 | 96,271 |
| Revenue | 141,569 | 134,996 | 129,896 | 138,316 |
| EBITDA | 7,864 | 5,940 | 2,791 | 9,564 |
| Net Income | 2,469 | 1,771 | (425) | 4,684 |
| Total Assets | 164,940 | 111,060 | 112,088 | 119,698 |
| Total Debt | 36,007 | 33,975 | 34,458 | 30,348 |
Hyundai Pharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hyundai Pharm Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hyundai Pharm Patents
Hyundai Pharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026054614-A1 | Novel compound and pharmaceutical composition comprising same | Pending | 09-Sep-2024 | ||
| WO-2025253265-A1 | Pharmaceutical composition for preventing or treating diabetes | Pending | 03-Jun-2024 | ||
| WO-2025193045-A1 | Novel compound, and pharmaceutical composition for prevention or treatment of cancer comprising same | Pending | 12-Mar-2024 | ||
| WO-2025095751-A1 | Novel compound, and pharmaceutical composition for prevention or treatment of cancer comprising same | Inactive | 30-Oct-2023 | ||
| WO-2025023511-A1 | Pharmaceutical composition and preparation method therefor | Inactive | 21-Jul-2023 | A61K9/2013 |
Hyundai Pharm Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hyundai Pharm Investments (2)
Hyundai Pharm’s most recent deal was a Later Stage VC with Jeongseok Chemical for . The deal was made on 14-Dec-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jeongseok Chemical | 14-Dec-2023 | Later Stage VC | Industrial Supplies and Parts | ||
| Txinno Bioscience | 19-Mar-2023 | Early Stage VC | Drug Discovery |
Hyundai Pharm ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Hyundai Pharm FAQs
-
When was Hyundai Pharm founded?
Hyundai Pharm was founded in 1965.
-
Where is Hyundai Pharm headquartered?
Hyundai Pharm is headquartered in Seoul, South Korea.
-
What is the size of Hyundai Pharm?
Hyundai Pharm has 406 total employees.
-
What industry is Hyundai Pharm in?
Hyundai Pharm’s primary industry is Pharmaceuticals.
-
Is Hyundai Pharm a private or public company?
Hyundai Pharm is a Public company.
-
What is Hyundai Pharm’s stock symbol?
The ticker symbol for Hyundai Pharm is 004310.
-
What is the current stock price of Hyundai Pharm?
As of 12-Nov-2026 the stock price of Hyundai Pharm is $4.86.
-
What is the current market cap of Hyundai Pharm?
The current market capitalization of Hyundai Pharm is $150M.
-
What is Hyundai Pharm’s current revenue?
The trailing twelve month revenue for Hyundai Pharm is $142M.
-
What is Hyundai Pharm’s annual earnings per share (EPS)?
Hyundai Pharm’s EPS for 12 months was $0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
